These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4853172)

  • 1. Metabolic conditioning and metabolic actuation: experimental approaches to cancer chemotherapy involving combinations of metabolites and antimetabolites.
    Bloch A
    Cancer Chemother Rep; 1974; 58(4):471-7. PubMed ID: 4853172
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of nucleoside and nucleotide metabolism.
    Henderson JF; Paterson AR; Caldwell IC; Paul B; Chan MC; Lau KF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):71-85. PubMed ID: 4676703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimetabolites in the treatment of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. II].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Apr; 69(2):153-76. PubMed ID: 4134598
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.
    Lau KF; Henderson JF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):95-109. PubMed ID: 4499907
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of solid tumors.
    Alberto P
    Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antineoplastic and immunodepressive activity of purinylglutathionyl disulfide].
    Sokolov AV; Syrkin AB; Fontalin LN; PevnitskiÄ­ LA; Solov'ev VV
    Farmakol Toksikol; 1972 Jul; 35(4):473-7. PubMed ID: 5050282
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory effects of the arabinosides of 6-mercaptopurine and cytosine on purine and pyrimidine metabolism.
    Kimball AP; Bowman B; Bush PS; Herriot J; LePage GA
    Cancer Res; 1966 Jul; 26(7):1337-43. PubMed ID: 5911573
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various aspects of the problem of selectivity in the chemotherapy of cancer].
    Velousova AK
    Vopr Onkol; 1969; 15(8):96-110. PubMed ID: 4901626
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific histotropism of antineoplastic agents].
    Berti T
    Clin Ter; 1970 Nov; 55(4):293-303. PubMed ID: 4930868
    [No Abstract]   [Full Text] [Related]  

  • 11. Combinations of 6-mercaptopurine (NSC-755) and 6-(methylmercapto)purine ribonucleoside (NSC-40774) in therapy of Ehrlich ascites carcinoma.
    Wang MC; Simpson AI; Paterson AR
    Cancer Chemother Rep; 1967 Jun; 51(3):101-9. PubMed ID: 6043733
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antimetabolites of orotic acid].
    Golovinsky E
    Vopr Med Khim; 1972; 18(5):451-60. PubMed ID: 4343977
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of various carcinostatic agents on acridine orange uptake by Ehrlich ascites carcinoma cells.
    Hano K; Iwata H; Morita S
    Gan; 1966 Feb; 57(1):19-26. PubMed ID: 4959535
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the primary immune response in man by anti-metabolites.
    Hersh EM; Carbone PP; Wong VG; Freireich EJ
    Cancer Res; 1965 Aug; 25(7):997-1001. PubMed ID: 5843275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influencing the immune status of cancer patients through chemotherapy].
    Micksche M
    Wien Med Wochenschr; 1975 Dec; 125(50-52):729-35. PubMed ID: 779283
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of antineoplastic drugs on blood and tumor water-electrolyte balance in mice and rats].
    PashinskiÄ­ BG
    Vopr Onkol; 1969; 15(6):65-8. PubMed ID: 5820355
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiopurine nucleotide synthesis in a 6-MP-resistant subline of the Ehrlich ascites carcinoma and growth inhibition by certain antimetabolites.
    PATERSON AR
    Can J Biochem Physiol; 1960 Oct; 38():1129-35. PubMed ID: 13733290
    [No Abstract]   [Full Text] [Related]  

  • 18. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of some drugs on hexosamine synthesis in Ehrlich ascites carcinoma cells and on hyaluronic acid content in the ascitic fluid.
    Hano K; Nishino Y
    Gan; 1965 Aug; 56(4):367-75. PubMed ID: 4954023
    [No Abstract]   [Full Text] [Related]  

  • 20. DEMETHYLATION OF PURINE ANALOGS BY MICROSOMAL ENZYMES FROM MOUSE LIVER.
    HENDERSON JF; MAZEL P
    Biochem Pharmacol; 1964 Feb; 13():207-10. PubMed ID: 14127300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.